Detection of Atrial Fibrillation in Patients With Excessive Supraventricular Activity
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The aim of the proposed study is to determine if individuals with excessive supraventricular ectopic activity (ESVEA) on Holter recording should be subjected to prolonged screening with Event loop recorder in order to detect previously undiagnosed Atrial fibrillation / flutter. Other biomarkers such as plasma biomarkers, high-end echocardiography and assessment of blood pressure and atrial stiffness will be studied and compared in ESVEA and control group as well as progression of atrial cardiomyopathy in ESVEA patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 70
Maximum Age: 89
Healthy Volunteers: t
View:
• Patients with at least 30 supraventricular extra systole (SVES)/h or a supraventricular run of at least 20 beats on a Holter recording.
Locations
Other Locations
Sweden
Danderyd Hospital
RECRUITING
Stockholm
Contact Information
Primary
Johan Engdahl
johan.engdahl@regionstockholm.se
0046812358242
Time Frame
Start Date: 2022-11-01
Estimated Completion Date: 2028-02-15
Participants
Target number of participants: 250
Treatments
ESVEA
ESVEA (Excessive supraventricular ectopic activity): Participants with at least 30 supraventricular extra systole (SVES)/h or a supraventricular run of at least 20 beats.
Non-ESVEA
Participants not meeting inclusion criteria
Related Therapeutic Areas
Sponsors
Leads: Karolinska Institutet
Collaborators: Danderyd Hospital